Centocor, Inc.
Patent Owner
Stats
- 70 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 29, 2013 most recent publication
Details
- 70 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,020 Total Citation Count
- May 07, 1982 Earliest Filing
- 144 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8361474 Anti-IL-12 antibody based vectors, host cells, and methods of production and usesApr 13, 10Jan 29, 13[A61K, C07H, C12P, C12N]
8277809 CXCL13 antagonists and their use for the treatment of inflammatory diseasesApr 20, 07Oct 02, 12[A61K]
8071103 Pharmaceutical composition comprising a human GLP-1 mimetibodyJul 18, 07Dec 06, 11[A61K, C07K]
8067191 Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levelsJun 06, 07Nov 29, 11[A61K, C12N, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0052,066 MARKERS AND METHODS FOR ASSESSING AND TREATING LUPUS PATIENTS SUSCEPTIBLE TO PHOTOPROVOCATIONAbandonedNov 06, 09Mar 01, 12[A61K, C12Q, G01N, A61P, C40B]
7744885 Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereofExpiredDec 07, 07Jun 29, 10[A61K, C07K]
2010/0074,901 HUMAN ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, METHODS AND USESAbandonedOct 15, 08Mar 25, 10[A61K, C07H, C12P, C12N, G01N, C07K]
2010/0034,819 HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS ON RENAL DISEASE ASSOCIATED ANEMIAAbandonedMar 30, 07Feb 11, 10[A61K, C12N]
2010/0028,904 WAY TO OBTAIN HIGH EXPRESSION CLONES OF MAMMALIAN CELLS USING A METHYLCELLULOSE WITH FLUORESCENT PROTEIN A OR G AND FLUORESCENT SCREENING METHODAbandonedMar 28, 08Feb 04, 10[C12Q, C12N, G01N]
2009/0325,873 HUMAN GLP-1 MIMETIBODIES, COMPOSITIONS, METHODS AND USESAbandonedJul 18, 07Dec 31, 09[A61K, C07H, C12Q, C12P, C12N, A61P, C07K]
2009/0214,528 HOST CELL LINES FOR PRODUCTION OF ANTIBODY CONSTANT REGION WITH ENHANCED EFFECTOR FUNCTIONAbandonedAug 31, 06Aug 27, 09[A61K, C12P, C12N, C07K]
2009/0136,509 Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic ConditionsAbandonedOct 31, 08May 28, 09[A61K]
2009/0041,762 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factorAbandonedDec 13, 05Feb 12, 09[A61K, C12P]
2008/0311,034 Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector FunctionAbandonedApr 28, 08Dec 18, 08[A61K, C07H, C12N, A01K, A61P, C07K]
7425330 Methods of inhibiting TNF.alpha. activity in the blood of a patientExpiredOct 16, 06Sep 16, 08[A61K]
7416729 Methods of treating rheumatoid arthritis with anti-TNF antibodiesExpiredJun 18, 07Aug 26, 08[A61K]
7404955 Methods of inhibiting or neutralizing TNF.alpha. in patients with tissue injuryExpiredAug 02, 05Jul 29, 08[A61K]
2008/0044,420 Anti-IL-13 antibodies, compositions, methods and usesAbandonedMay 10, 06Feb 21, 08[A61K, C12P, C12N, A01K, G01N, A61P, C07K, A61M]
2007/0298,040 Methods of treating seronegative arthropathy with anti-TNF antibodiesAbandonedApr 10, 06Dec 27, 07[A61K]
2007/0203,064 TLR3 Glycosylation Site Muteins and Methods of UseAbandonedOct 30, 06Aug 30, 07[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.